NCT03637998

Brief Summary

This pilot project will provide an understanding of the contextual variables responsible for chronic low back pain. These variables include, genetic variation, pain sensitivity, reactivity, pain catastrophizing, perceived stress and kinesiphobia. The purpose is to understand the initial efficacy of self-management (SM) strategies on each of these contextual variables, in an effort to inform a personalized approach to managing chronic low back pain and its effect on improved health outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 20, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

September 21, 2018

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

November 28, 2023

Status Verified

November 1, 2023

Enrollment Period

3.3 years

First QC Date

August 16, 2018

Last Update Submit

November 27, 2023

Conditions

Keywords

Gene expressionQuantitative Sensory TestingGenotyping

Outcome Measures

Primary Outcomes (1)

  • Change in physical activity

    Fitbit for activity tracker

    Baseline, 2, 4, 6, 8, 10 and 12 weeks

Secondary Outcomes (5)

  • Change in gene expression profiles

    Baseline and 12 weeks post-intervention

  • Change in pain sensitivity

    Baseline and 12 weeks post-intervention

  • Relationship between pain self-management and pain severity

    Baseline, 2, 4, 6, 8, 10 and 12 weeks

  • Relationship between pain self-management and pain interferance

    Baseline, 2, 4, 6, 8, 10 and 12 weeks

  • Relationship between pain self-management and quality of life

    Baseline, 2, 4, 6, 8, 10 and 12 weeks

Study Arms (1)

PROPEL

EXPERIMENTAL

The Problem-solving Pain to Enhance Living Well (PROPEL) intervention entails each participant watching 10 video modules via REDCap. These modules include: (1) pain neurophysiology, (2) catastrophizing, (3) stress reactivity, (4) fear of movement, (5) progressive relaxation, (6) deep breathing, (7) guided imagery, (8) heat, ice and stretching, (9) strategies for physical activity self-activation and (10) problem-solving.

Behavioral: Problem-solving Pain to Enhance Living Well (PROPEL)

Interventions

PROPEL incorporates evidence-based, standard of care methods to promote physical activity among individuals with pain, and tools to improve knowledge, skills and confidence to cope with cLBP. The focus is self-management of cLBP. All eligible participants will then undergo baseline data collection, which entails completion of study questionnaires, quantitative sensory testing (QST) and venipuncture for collection of a blood specimen. Participants will be provided with the information to access the PROPEL intervention. All participants will be asked to complete questionnaires at 2, 4, 6, 8, and 10 weeks following baseline testing. At 12 weeks, participants will be scheduled for a final data collection visit, which will follow the same procedures as the baseline visit.

PROPEL

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • be 18-60 years of age;
  • have nonspecific cLBP (≥4 on the numeric rating scale; NRS) present for at least 3 out of the last 6 months and ≥ half the days in the past 6 months;
  • comprehend English (due to lack of reliability and validity of study instruments and the intervention in non-English populations).
  • Have daily access to a computer, tablet or smartphone with access to internet
  • Have less than 150 minutes of moderate physical activity a week
  • Be willing to wear activity tracker for 12 weeks

You may not qualify if:

  • Chronic pain at another site or associated with a painful condition (eg., fibromyalgia, neuropathy, rheumatoid arthritis)
  • history of comorbidities that affect sensorimotor function (eg., multiple sclerosis, cancer, spinal cord injury, diabetes)
  • previous spinal surgery within last 1 year
  • presence of neurological deficits such as weakness in the lower extremities (motor strength 4/5 of quads, glutes, hamstrings, EHL)
  • bowel or bladder dysfunction such as difficulty voiding or incontinence
  • sciatica or (+) leg raise
  • positive Romberg test
  • being pregnant or within 3 months postpartum
  • history of psychological disorders (major depression, bipolar disorder, schizophrenia)
  • identification of any "red flag" condition in the volunteer's past medical history that suggests specific LBP as determined by Dr. Kim such as conditions or medications that can affect pain sensitivity
  • injury to non-dominant hand or presence of open skin lesions, disturbed sensation, carpal tunnel or rash

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Connecticut

Storrs, Connecticut, 06269, United States

Location

Related Publications (1)

  • Xu W, Zhang Y, Wang Z, Dorsey SG, Starkweather A, Kim K. Pain self-management plus activity tracking and nurse-led support in adults with chronic low back pain: feasibility and acceptability of the problem-solving pain to enhance living well (PROPEL) intervention. BMC Nurs. 2023 Jun 25;22(1):217. doi: 10.1186/s12912-023-01365-y.

Related Links

MeSH Terms

Interventions

Mometasone Furoate

Intervention Hierarchy (Ancestors)

PregnadienediolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic Compounds

Study Officials

  • Wanli Xu, PhD

    University of Connecticut

    PRINCIPAL INVESTIGATOR
  • Angela Starkweather, PhD

    University of Connecticut

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 16, 2018

First Posted

August 20, 2018

Study Start

September 21, 2018

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

November 28, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will share

All of the individual participant data that are part of National Institute of Nursing Research (NINR) designated common data elements collected during the trial, after de-identification have been submitted to NIH repository at the Common Data Repository for Nursing Science (cdRNS). Data can be accessed by directly submitting requests at that website. When will data be available (start and end dates)? Immediately. No end date. With whom? Anyone who wishes to access the data and creates an account on cdRNS.nih.gov. By what mechanism will data be made available? Data are available at cdRNS.nih.gov

Time Frame
Within 2 years
Access Criteria
Requests will be submitted through the cdRNS website
More information

Locations